These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 35443459)
41. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. Davutoglu V; Celik A; Aksoy M J Heart Valve Dis; 2005 Mar; 14(2):251-6. PubMed ID: 15792187 [TBL] [Abstract][Full Text] [Related]
42. Prevalence of Frailty and Evaluation of Associated Variables Among COPD Patients. Dias LS; Ferreira ACG; da Silva Junior JLR; Conte MB; Rabahi MF Int J Chron Obstruct Pulmon Dis; 2020; 15():1349-1356. PubMed ID: 32606644 [TBL] [Abstract][Full Text] [Related]
43. Effects of omega-3 supplementation on quality of life, nutritional status, inflammatory parameters, lipid profile, exercise tolerance and inhaled medications in chronic obstructive pulmonary disease. Fekete M; Szarvas Z; Fazekas-Pongor V; Lehoczki A; Tarantini S; Varga JT Ann Palliat Med; 2022 Sep; 11(9):2819-2829. PubMed ID: 35948470 [TBL] [Abstract][Full Text] [Related]
44. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176 [TBL] [Abstract][Full Text] [Related]
45. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity]. Liu H; Xu JY Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993 [TBL] [Abstract][Full Text] [Related]
46. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study. Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P Respiration; 2020; 99(7):606-616. PubMed ID: 32659763 [TBL] [Abstract][Full Text] [Related]
47. Prevalence and clinical impact of frailty in COPD: a systematic review and meta-analysis. Wang L; Zhang X; Liu X BMC Pulm Med; 2023 May; 23(1):164. PubMed ID: 37173728 [TBL] [Abstract][Full Text] [Related]
48. Effects of High-Dose Vitamin D Replacement on the Serum Levels of Systemic Inflammatory Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Dastan F; Salamzadeh J; Pourrashid MH; Edalatifard M; Eslaminejad A COPD; 2019 Aug; 16(3-4):278-283. PubMed ID: 31550915 [TBL] [Abstract][Full Text] [Related]
49. Association between inflammatory markers and frailty in institutionalized older men. Lai HY; Chang HT; Lee YL; Hwang SJ Maturitas; 2014 Nov; 79(3):329-33. PubMed ID: 25132319 [TBL] [Abstract][Full Text] [Related]
50. Associations between BODE index and systemic inflammatory biomarkers in COPD. Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400 [TBL] [Abstract][Full Text] [Related]
51. Effect of dyspnea on frailty stages and related factors in Taiwanese men with COPD. Chen PJ; Yang KY; Perng WC; Lin KC; Wang KY Int J Chron Obstruct Pulmon Dis; 2018; 13():2463-2469. PubMed ID: 30147312 [TBL] [Abstract][Full Text] [Related]
52. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD. de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519 [TBL] [Abstract][Full Text] [Related]
53. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome]. Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994 [TBL] [Abstract][Full Text] [Related]
54. The Correlation of Serum Brain Natriuretic Peptide and Interleukin-6 with Quality of Life Using the Chronic Obstructive Pulmonary Disease Assessment Test. Ghobadi H; Aslani MR; Hosseinian A; Farzaneh E Med Princ Pract; 2017; 26(6):509-515. PubMed ID: 29131048 [TBL] [Abstract][Full Text] [Related]
55. Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease. Kurt OK; Tosun M; Kurt EB; Talay F Inflammation; 2015 Feb; 38(1):89-93. PubMed ID: 25303877 [TBL] [Abstract][Full Text] [Related]
56. Differences in physical activity according to mMRC grade in patients with COPD. Hayata A; Minakata Y; Matsunaga K; Nakanishi M; Yamamoto N Int J Chron Obstruct Pulmon Dis; 2016; 11():2203-2208. PubMed ID: 27695306 [TBL] [Abstract][Full Text] [Related]
57. GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD). Rebordosa C; Plana E; Aguado J; Thomas S; García-Gil E; Perez-Gutthann S; Castellsague J Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):126-133. PubMed ID: 29740896 [TBL] [Abstract][Full Text] [Related]
58. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Lee TM; Lin MS; Chang NC Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772 [TBL] [Abstract][Full Text] [Related]
59. The effect of comorbidities on COPD assessment: a pilot study. Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525 [TBL] [Abstract][Full Text] [Related]
60. High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD. Liu SF; Wang CC; Chin CH; Chen YC; Lin MC Arch Bronconeumol; 2011 Sep; 47(9):427-32. PubMed ID: 21821335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]